Related content

5-Fluorouracil Cardiotoxicity: A Unique Mechanism for Ischaemic Cardiopathy and Cardiac Failure?

By Lieutaud T.   Brain E.   Golgran-Toledano D.   Vincent F.   Cvitkovic E.   Leclercq B.   Escudier B.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 368-369

Elsevier

Access to resources Recommend Favorite

Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice

By Letari Ornella   Booth Catherine   Bonazzi Albino   Garofalo Paolo   Makovec Francesco   Rovati Lucio   Caselli Gianfranco  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

5-Fluorouracil-induced Raynaud's Phenomenon

By ter Steege J.C.A.   Koster-Kamphuis L.   van Straaten E.A.   Forget P.P.   Buurman W.A.   Papamichael D.   Amft N.   Slevin M.L.   D'Cruz D.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1983-1983

Elsevier

Access to resources Recommend Favorite

Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer

By Yamanaka Takeharu   Matsumoto Shigemi   Teramukai Satoshi   Ishiwata Ryota   Nagai Yoji   Fukushima Masanori  

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 129-134

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials

By                

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite